ER

Equity Resources Group

North America, Massachusetts, United States, Cambridge

Description

Equity Resources Group is a U.S.-based private equity firm that invests residential and commercial real estate.

Investor Profile

Equity Resources Group has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Enterprise Software
  • Information Services
  • Real Time
  • Software
  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Equity Resources Group frequently co-invest with?

LH
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 1
Velocity Partners
North America, Washington, United States, Bellevue
Co-Investments: 2
Battelle Ventures
North America, New Jersey, United States, Trenton
Co-Investments: 2
North Hill Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Dunrath Capital
North America, Illinois, United States, Western Springs
Co-Investments: 2
Apex Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Equity Resources Group?

Metatomix

Dedham, Massachusetts, United States

Metatomix is an intelligent, real-time connector of disparate data to better understand business information from multiple data sources.

Enterprise SoftwareInformation ServicesReal TimeSoftware
Series BMay 22, 2007
Amount Raised: $7,000,000
Metatomix

Dedham, Massachusetts, United States

Metatomix is an intelligent, real-time connector of disparate data to better understand business information from multiple data sources.

Enterprise SoftwareInformation ServicesReal TimeSoftware
Series UnknownMay 18, 2006
Amount Raised: $11,300,000
BioStratum

Durham, North Carolina, United States

BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 22, 2003
Amount Raised: $9,500,000